HemoGAD Technologies is a company specializing in the field of medical device research for the management of hereditary hemochromatosis, iron deficiency anemia, and other iron overload and deficiency conditions. It conducts a research to find the evidence that salivary ferritin expression is indicative of the total body iron status.